August 3, 2022
- COUR NanoParticle technology halts Type 1 diabetes progression
- Gut Microbe Peptide Implicated In Triggering Type 1 Diabetes
- The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes
- Potential target for type 1 diabetes treatment
- Novel Insights into the Pathogenic Impact of Diabetes on the Gastrointestinal Tract
- Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease
- Association between new onset type 1 diabetes and real-world antibiotics and neonicotinoids’ exposure-related gut microbiota perturbation
- Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets (Full text HTML, PDF)
- From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes (Full text HTML)
- First-emerging islet autoantibody and glucose metabolism: search for type 1 diabetes subtypes
- BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report
- Tissue Engineering Approaches and Generation of Insulin-Producing Cells to Treat Type 1 Diabetes
